The DOI matches its Crossref record; 159 of the 159 references it cites were found in a registry or an index.
The genetics of malignant melanoma: lessons from mouse and man
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Kantarjian, H., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,243
Mammalian MAP kinase signalling cascades
Chang, L., & Karin, M. (2001) · Nature · doi:10.1038/35065000 · Cited by 5,111
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
Demetri, G. D., von Mehren, M., Blanke, C. D., Van den Abbeele, A. D., Eisenberg, B., Roberts, P. J., Heinrich, M. C., Tuveson, D. A., Singer, S., Janicek, M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020461 · Cited by 4,389
Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases
Johnson, G. L., & Lapadat, R. (2002) · Science · doi:10.1126/science.1072682 · Cited by 4,295
Dermatology in General Medicine.
(1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-6-923_2 · Cited by 3,794
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification
Gorre, M. E., Mohammed, M., Ellwood, K., Hsu, N., Paquette, R., Rao, P. N., & Sawyers, C. L. (2001) · Science · doi:10.1126/science.1062538 · Cited by 3,104
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0497-356 · Cited by 2,741
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81780-8 · Cited by 2,551
Balch, C. M., Soong, S.-J., Gershenwald, J. E., Thompson, J. F., Reintgen, D. S., Cascinelli, N., Urist, M., McMasters, K. M., Ross, M. I., Kirkwood, J. M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3622 · Cited by 2,388
Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product
Bottaro, D. P., Rubin, J. S., Faletto, D. L., Chan, A. M.-L., Kmiecik, T. E., Vande Woude, G. F., & Aaronson, S. A. (1991) · Science · doi:10.1126/science.1846706 · Cited by 2,236
Liaw, D., Marsh, D. J., Li, J., Dahia, P. L. M., Wang, S. I., Zheng, Z., Bose, S., Call, K. M., Tsou, H. C., Peacoke, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-64 · Cited by 2,091
The epidemiology of UV induced skin cancer
Armstrong, B. K., & Kricker, A. (2001) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/s1011-1344(01)00198-1 · Cited by 1,811
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., & Carson, D. A. (1994) · Nature · doi:10.1038/368753a0 · Cited by 1,742
High frequency of BRAF mutations in nevi
Pollock, P. M., Harper, U. L., Hansen, K. S., Yudt, L. M., Stark, M., Robbins, C. M., Moses, T. Y., Hostetter, G., Wagner, U., Kakareka, J., et al. (2003) · Nature Genetics · doi:10.1038/ng1054 · Cited by 1,730
c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism
Dang, C. V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.1 · Cited by 1,715
Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585
Self-citationPomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521
Self-citationPten is essential for embryonic development and tumour suppression
Cristofano, A. D., Pesce, B., Cordon-Cardo, C., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/1235 · Cited by 1,516
Ouelle, D. E., Zindy, F., Ashmun, R. A., & Sherr, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90214-7 · Cited by 1,485
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., & Roussel, M. F. (1998) · Genes & Development · doi:10.1101/gad.12.15.2424 · Cited by 1,245
RAF/RAS oncogenes and mismatch-repair status
Rajagopalan, H., Bardelli, A., Lengauer, C., Kinzler, K. W., Vogelstein, B., & Velculescu, V. E. (2002) · Nature · doi:10.1038/418934a · Cited by 1,224
Stott, F. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5001 · Cited by 1,167
A p16 INK4a -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human Melanoma
Wölfel, T., Hauer, M., Schneider, J., Serrano, M., Wölfel, C., Klehmann-Hieb, E., De Plaen, E., Hankeln, T., Meyer zum Büschenfelde, K.-H., & Beach, D. (1995) · Science · doi:10.1126/science.7652577 · Cited by 1,154
BRAF and RAS mutations in human lung cancer and melanoma.
Brose, M. S., Volpe, P., Feldman, M. D., Kumar, M. S., Rishi, I., Gerrero, R. M., Einhorn, E., Herlyn, M., Minna, J. D., Nicholson, A. G., et al. (2002) · PubMed · Cited by 1,048
Valverde, P., Healy, E., Jackson, I., Rees, J. L., & Thody, A. J. (1995) · Nature Genetics · doi:10.1038/ng1195-328 · Cited by 999
Germline p16 mutations in familial melanoma
Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A. T., Ally, D. S., Sheahan, M. D., Clark, W. H., Tucker, M. A., & Dracopoli, N. C. (1994) · Nature Genetics · doi:10.1038/ng0994-15 · Cited by 977
Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems
Podsypanina, K., Ellenson, L. H., Nemes, A., Gu, J., Tamura, M., Yamada, K. M., Cordon-Cardo, C., Catoretti, G., Fisher, P. E., & Parsons, R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1563 · Cited by 946
Blackwell, T. K., & Weintraub, H. (1990) · Science · doi:10.1126/science.2174572 · Cited by 930
The p16INK4a/CDKN2A tumor suppressor and its relatives
Ruas, M., & Peters, G. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(98)00017-1 · Cited by 911
Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
Kamijo, T., Weber, J. D., Zambetti, G., Zindy, F., Roussel, M. F., & Sherr, C. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8292 · Cited by 899
The pathogenesis of melanoma induced by ultraviolet radiation
Gilchrest, B. A., Eller, M. S., Geller, A. C., & Yaar, M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904293401707 · Cited by 876
Essential role for oncogenic Ras in tumour maintenance
Chin, L., Tam, A., Pomerantz, J., Wong, M., Holash, J., Bardeesy, N., Shen, Q., O'Hagan, R., Pantginis, J., Zhou, H., et al. (1999) · Nature · doi:10.1038/22788 · Cited by 875
Self-citationLi, D., & Sun, H. (1997) · PubMed · Cited by 866
Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
Kamb, A., Shattuck-Eidens, D., Eeles, R., Liu, Q., Gruis, N. A., Ding, W., Hussey, C., Tran, T., Miki, Y., Weaver-Feldhaus, J., et al. (1994) · Nature Genetics · doi:10.1038/ng0994-22 · Cited by 855
Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis
Sharpless, N. E., Bardeesy, N., Lee, K.-H., Carrasco, D., Castrillon, D. H., Aguirre, A. J., Wu, E. A., Horner, J. W., & DePinho, R. A. (2001) · Nature · doi:10.1038/35092592 · Cited by 848
Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma
Zuo, L., Weger, J., Yang, Q., Goldstein, A. M., Tucker, M. A., Walker, G. J., Hayward, N., & Dracopoli, N. C. (1996) · Nature Genetics · doi:10.1038/ng0196-97 · Cited by 818 · cited 1×
“Affected individuals possess either an Arg24Cys or Arg24His mutatio”
BackgroundSuzuki, A., de la Pompa, J. L., Stambolic, V., Elia, A. J., Sasaki, T., Barrantes, I. D. B., Ho, A., Wakeham, A., ltie, A., Khoo, W., et al. (1998) · Current Biology · doi:10.1016/s0960-9822(07)00488-5 · Cited by 818
Cyclic AMP a Key Messenger in the Regulation of Skin Pigmentation
BUSCÀ, R., & BALLOTTI, R. (2000) · Pigment Cell Research · doi:10.1034/j.1600-0749.2000.130203.x · Cited by 806
Sherr, C. J., & DePinho, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)00046-5 · Cited by 745
Germline mutations in PTEN are present in Bannayan-Zonana syndrome
Marsh, D. J., Dahia, P. L. M., Zheng, Z., Liaw, D., Parsons, R., Gorlin, R. J., & Eng, C. (1997) · Nature Genetics · doi:10.1038/ng0897-333 · Cited by 655
Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies
Whiteman, D. C., Whiteman, C. A., & Green, A. C. (2001) · Cancer Causes & Control · doi:10.1023/a:1008980919928 · Cited by 633
E1A signaling to p53 involves the p19ARFtumor suppressor
de Stanchina, E., McCurrach, M. E., Zindy, F., Shieh, S.-Y., Ferbeyre, G., Samuelson, A. V., Prives, C., Roussel, M. F., Sherr, C. J., & Lowe, S. W. (1998) · Genes & Development · doi:10.1101/gad.12.15.2434 · Cited by 609
Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice
Krimpenfort, P., Quon, K. C., Mooi, W. J., Loonstra, A., & Berns, A. (2001) · Nature · doi:10.1038/35092584 · Cited by 568 · cited 1×
“Interestingly, animals that are specifically deficient for Ink4a show a low frequency of melanoma spontaneously or after carcinogen treatment with DMBA (7,12-dimethylbenzanthracene”
BackgroundCancer revoked: oncogenes as therapeutic targets
Felsher, D. W. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1070 · Cited by 556
UV-induced DNA damage, repair, mutations and oncogenic pathways in skin cancer
de Gruijl, F. R., van Kranen, H. J., & Mullenders, L. H. F. (2001) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/s1011-1344(01)00199-3 · Cited by 544
Russo, A. A., Tong, L., Lee, J.-O., Jeffrey, P. D., & Pavletich, N. P. (1998) · Nature · doi:10.1038/26155 · Cited by 524
Bastian, B. C., LeBoit, P. E., Hamm, H., Bröcker, E.-B., & Pinkel, D. (1998) · PubMed · Cited by 513
Microphthalmia Gene Product as a Signal Transducer in cAMP-Induced Differentiation of Melanocytes
Bertolotto, C., Abbe, P., Hemesath, T. J., Bille, K., Fisher, D. E., Ortonne, J.-P., & Ballotti, R. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.3.827 · Cited by 512
Geographical Variation in the Penetrance of CDKN2A Mutations for Melanoma
Bishop, D. T. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.12.894 · Cited by 509
Palmer, J. S., Duffy, D. L., Box, N. F., Aitken, J. F., O'Gorman, L. E., Green, A. C., Hayward, N. K., Martin, N. G., & Sturm, R. A. (2000) · The American Journal of Human Genetics · doi:10.1086/302711 · Cited by 503
Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma.
Guldberg, P., Straten, P. T., Birck, A., Ahrenkiel, V., Kirkin, A. F., & Zeuthen, J. (1997) · PubMed · Cited by 480
PTEN signaling pathways in melanoma
Wu, H., Goel, V., & Haluska, F. G. (2003) · Oncogene · doi:10.1038/sj.onc.1206451 · Cited by 480
Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease
Nelen, M. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.8.1383 · Cited by 464
MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.
Teng, D., Hu, R. H., Lin, H., Davis, T., Iliev, D., Frye, C., Swedlund, B., Hansen, K. L., Vinson, V. L., Gumpper, K. L., et al. (1997) · PubMed · Cited by 463
INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53
Schmitt, C. A., McCurrach, M. E., de Stanchina, E., Wallace-Brodeur, R. R., & Lowe, S. W. (1999) · Genes & Development · doi:10.1101/gad.13.20.2670 · Cited by 458
Distinct requirements for Ras oncogenesis in human versus mouse cells
Hamad, N. M., Elconin, J. H., Karnoub, A. E., Bai, W., Rich, J. N., Abraham, R. T., Der, C. J., & Counter, C. M. (2002) · Genes & Development · doi:10.1101/gad.993902 · Cited by 431
Dermatology in General Medicine
Parsons, J. L. (1994) · Archives of Dermatology · doi:10.1001/archderm.1994.01690070137028 · Cited by 426
Kennedy, C., ter Huurne, J., Berkhout, M., Gruis, N., Bastiaens, M., Bergman, W., Willemze, R., & Bouwes Bavinck, J. N. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01421.x · Cited by 407
Cooperative effects of INK4a and ras in melanoma susceptibility in vivo
Chin, L., Pomerantz, J., Polsky, D., Jacobson, M., Cohen, C., Cordon-Cardo, C., Horner, J. W., & DePinho, R. A. (1997) · Genes & Development · doi:10.1101/gad.11.21.2822 · Cited by 402
Self-citationSoufir, N. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.2.209 · Cited by 386
Neonatal sunburn and melanoma in mice
Noonan, F. P., Recio, J. A., Takayama, H., Duray, P., Anver, M. R., Rush, W. L., De Fabo, E. C., & Merlino, G. (2001) · Nature · doi:10.1038/35095108 · Cited by 386
Endothelins secreted from human keratinocytes are intrinsic mitogens for human melanocytes
Imokawa, G., Yada, Y., & Miyagishi, M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35817-4 · Cited by 385
Complex structure and regulation of the P16 (MTS1) locus.
Stone, S., Jiang, P., Dayananth, P., Tavtigian, S. V., Katcher, H. L., Parry, D., Peters, G., & Kamb, A. (1995) · PubMed · Cited by 383
Widlund, H. R., & Fisher, D. E. (2003) · Oncogene · doi:10.1038/sj.onc.1206443 · Cited by 371
Mechanisms of Ultraviolet Light‐Induced Pigmentation
Gilchrest, B. A., Park, H., Eller, M. S., & Yaar, M. (1996) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1996.tb02988.x · Cited by 364
Hsu, M.-Y., Meier, F. E., Nesbit, M., Hsu, J.-Y., Van Belle, P., Elder, D. E., & Herlyn, M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65023-7 · Cited by 363
Characterization of Melanocyte Stimulating Hormone Receptor Variant Alleles in Twins with Red Hair
Box, N. F., Wyeth, J. R., O'Gorman, L. E., Martin, N. G., & Sturm, R. A. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.11.1891 · Cited by 340
Mao, L., Merlo, A. U., Bedi, G. C., Shapiro, G. I., Edwards, C. D., Rollins, B. J., & Sidransky, D. (1995) · PubMed · Cited by 329
Busca, R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.12.2900 · Cited by 326
Genetics of melanoma predisposition
Hayward, N. K. (2003) · Oncogene · doi:10.1038/sj.onc.1206445 · Cited by 321
(1984) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/73.1.75 · Cited by 318
MC1R Genotype Modifies Risk of Melanoma in Families Segregating CDKN2A Mutations
Box, N. F., Duffy, D. L., Chen, W., Stark, M., Martin, N. G., Sturm, R. A., & Hayward, N. K. (2001) · The American Journal of Human Genetics · doi:10.1086/323412 · Cited by 310
Missense mutations of the BRAF gene in human lung adenocarcinoma.
Naoki, K., Chen, T. H., Richards, W. G., Sugarbaker, D. J., & Meyerson, M. M. (2002) · PubMed · Cited by 287
Cell-cycle regulators and cancer
Kamb, A. (1995) · Trends in Genetics · doi:10.1016/s0168-9525(00)89027-7 · Cited by 284
A germline deletion of p14ARF but not CDKN2A in a melanoma-neural system tumour syndrome family
Randerson-Moor, J. A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.1.55 · Cited by 281
Pleiotropic effects of the melanocortin 1 receptor (MC1R) gene on human pigmentation
Flanagan, N. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.17.2531 · Cited by 278
Mutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma
Liu, L., Dilworth, D., Gao, L., Monzon, J., Summers, A., Lassam, N., & Hogg, D. (1999) · Nature Genetics · doi:10.1038/5082 · Cited by 276
Mitogen-actived protein kinase activation is an early event in melanoma progression.
Cohen, C., Zavala-Pompa, Á., Sequeira, J., Shoji, M., Sexton, D. G., Cotsonis, G., Cerimele, F., Govindarajan, B., Macaron, N. C., & Arbiser, J. L. (2002) · PubMed · Cited by 275
Otsuka, T., Takayama, H., Sharp, R., Celli, G. B., LaRochelle, W. J., Bottaro, D. P., Ellmore, N., Vieira, W., Owens, J. W., Anver, M. R., et al. (1998) · PubMed · doi:10.5281/zenodo.894795 · Cited by 268
Latres, E. (2000) · The EMBO Journal · doi:10.1093/emboj/19.13.3496 · Cited by 257
Melanocortin 1 Receptor Variants in an Irish Population
Smith, R., Healy, E., Siddiqui, S., Flanagan, N., Steijlen, P. M., Rosdahl, I., Jacques, J. P., Rogers, S., Turner, R., Jackson, I. J., et al. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00252.x · Cited by 248
Bastian, B. C., Kashani–Sabet, M., Hamm, H., Godfrey, T. E., Moore, D. H., Bröcker, E.-B., LeBoit, P. E., & Pinkel, D. (2000) · PubMed · Cited by 245
The melanocortin-1-receptor gene is the major freckle gene
Bastiaens, M. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.16.1701 · Cited by 236
Influence of sun exposures during childhood and during adulthood on melanoma risk
Autier, P., & Doré, J. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980812)77:4<533::aid-ijc10>3.0.co;2-7 · Cited by 234
Price, E. R., Horstmann, M. A., Wells, A. G., Weilbaecher, K. N., Takemoto, C. M., Landis, M. W., & Fisher, D. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.33042 · Cited by 225
Skin colour and skin cancer –MC1R, the genetic link
Sturm, R. A. (2002) · Melanoma Research · doi:10.1097/00008390-200209000-00001 · Cited by 224
Quelle, D. E., Cheng, M., Ashmun, R. A., & Sherr, C. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.669 · Cited by 220
Angiogenesis, lymphangiogenesis, and melanoma metastasis
Streit, M., & Detmar, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206457 · Cited by 219
Li, G., Schaider, H., Satyamoorthy, K., Hanakawa, Y., Hashimoto, K., & Herlyn, M. (2001) · Oncogene · doi:10.1038/sj.onc.1205034 · Cited by 212
Albino, A. P., Nanus, D. M., Mentle, I. R., Cordon‐Cardo, C., McNutt, N. S., Bressler, J., & Andreeff, M. (1989) · PubMed · Cited by 212
Shifts in cadherin profiles between human normal melanocytes and melanomas.
Hsu, M., Wheelock, M. J., Johnson, K. R., & Herlyn, M. (1996) · PubMed · Cited by 212
Natali, P., Nicotra, M., Di Renzo, M., Prat, M., Bigotti, A., Cavaliere, R., & Comoglio, P. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.422 · Cited by 205
Human melanocortin 1 receptor variants, receptor function and melanocyte response to UV radiation
Scott, M. C., Wakamatsu, K., Ito, S., Kadekaro, A. L., Kobayashi, N., Groden, J., Kavanagh, R., Takakuwa, T., Virador, V., Hearing, V. J., et al. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.11.2349 · Cited by 203
CDKN2A Variants in a Population-Based Sample of Queensland Families With Melanoma
Aitken, J., Welch, J., Duffy, D., Milligan, A., Green, A., Martin, N., & Hayward, N. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.5.446 · Cited by 200
Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth
Schreiber-Agus, N., Meng, Y., Hoang, T., Hou, H., Chen, K., Greenberg, R., Cordon-Cardo, C., Lee, H.-W., & DePinho, R. A. (1998) · Nature · doi:10.1038/31008 · Cited by 192
Genotype-Phenotype Relationships in U.S. Melanoma-Prone Families With CDKN2A and CDK4 Mutations
Goldstein, A. M. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.12.1006 · Cited by 192
Melanoma development and progression: a conspiracy between tumor and host
Hsu, M.-Y., Meier, F., & Herlyn, M. (2002) · Differentiation · doi:10.1046/j.1432-0436.2002.700906.x · Cited by 190
Pollock, P. M., Pearson, J. V., & Hayward, N. K. (1996) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199602)15:2<77::aid-gcc1>3.0.co;2-0 · Cited by 189
Development of melanocyte precursors from the vertebrate neural crest
Dupin, E., & Le Douarin, N. M. (2003) · Oncogene · doi:10.1038/sj.onc.1206460 · Cited by 188
Halaban, R., Rubin, J. S., Funasaka, Y., Cobb, M. H., Boulton, T. G., Faletto, D. L., Rosen, E. M., Chan, A. M.-L., Yoko, K., & White, W. L. (1992) · PubMed · Cited by 183
Analysis of N- and K-Ras Mutations in the Distinctive Tumor Progression Phases of Melanoma
Stas, M., Degreef, H., Demunter, A., De Wolf-Peeters, C., & van den Oord, J. J. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01601.x · Cited by 176
Melanocortin-1 Receptor Variant R151C Modifies Melanoma Risk in Dutch Families with Melanoma
van der Velden, P. A., Sandkuijl, L. A., Bergman, W., Pavel, S., van Mourik, L., Frants, R. R., & Gruis, N. A. (2001) · The American Journal of Human Genetics · doi:10.1086/323411 · Cited by 173
A melanoma-associated germline mutation in exon 1β inactivates p14ARF
Rizos, H., Puig, S., Badenas, C., Malvehy, J., Darmanian, A. P., Jiménez, L., Milà, M., & Kefford, R. F. (2001) · Oncogene · doi:10.1038/sj.onc.1204728 · Cited by 171
Dual Inactivation of RB and p53 Pathways in RAS-Induced Melanomas
Bardeesy, N., Bastian, B. C., Hezel, A., Pinkel, D., DePinho, R. A., & Chin, L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.6.2144-2153.2001 · Cited by 166
Self-citationInvasive melanoma in Cdk4-targeted mice
Sotillo, R., García, J. F., Ortega, S., Martín, J., Dubus, P., Barbacid, M., & Malumbres, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241338598 · Cited by 164
Walker, G. J., Flores, J. F., Glendening, J. M., Lin, A. H., Markl, I. D. C., & Fountain, J. W. (1998) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199806)22:2<157::aid-gcc11>3.0.co;2-n · Cited by 161
van Elsas, A., Zerp, S. F., van der Flier, S., Krüse, K. M., Aarnoudse, C. A., Hayward, N. K., Ruiter, D. J., & Schrier, P. I. (1996) · Europe PMC (PubMed Central) · Cited by 160
Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice
You, M. J., Castrillón, D. H., Bastian, B. C., O’Hagan, R. C., Bosenberg, M., Parsons, R. E., Chin, L., & DePinho, R. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022632099 · Cited by 153
Self-citationMalignant melanoma in transgenic mice.
Bradl, M., Klein–Szanto, A. J., Porter, S. D., & Mintz, B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.1.164 · Cited by 152
Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983-1996
Marrett, L. D., Nguyen, H. L., & Armstrong, B. K. (2001) · International Journal of Cancer · doi:10.1002/ijc.1203 · Cited by 148
Integration of Signals from Receptor Tyrosine Kinases and G Protein-Coupled Receptors
Lowes, V. L., Ip, N. Y., & Wong, Y. H. (2002) · Neurosignals · doi:10.1159/000057317 · Cited by 144
Tada, A., Suzuki, I., Im, S., Davis, M. B., Cornelius, J. R., Babcock, G. F., Nordlund, J. J., & ABDEL‐MALEK, Z. A. (1998) · PubMed · Cited by 144
Papp, T., Pemsel, H., Zimmermann, R., Bastrop, R., Weiss, D. G., & Schiffmann, D. (1999) · Journal of Medical Genetics · doi:10.1136/jmg.36.8.610 · Cited by 144
Melanocortin-1-receptor gene and sun sensitivity in individuals without red hair
Healy, E., Flannagan, N., Ray, A. J., Todd, C., Jackson, I. J., Matthews, J. N. S., Birch‐Machin, M. A., & Rees, J. L. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02042-0 · Cited by 143
Frequent Aberrant Methylation of p16INK4a in Primary Rat Lung Tumors
Swafford, D. S., Middleton, S. K., Palmisano, W. A., Nikula, K. J., Tesfaigzi, Y., Baylin, S. B., Herman, J. G., & Belinsky, S. A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1366 · Cited by 142
p19 Arf induces p53-dependent apoptosis during Abelson virus-mediated pre-B cell transformation
Radfar, A., Unnikrishnan, I., Lee, H., DePinho, R. A., & Rosenberg, N. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13194 · Cited by 140
Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma.
Flores, J. F., Walker, G. J., Glendening, J. M., Haluska, F. G., Castresana, J. S., Rubio, M., Pastorfide, G. C., Boyer, L. A., Kao, W. H., Bulyk, M. L., et al. (1996) · PubMed · Cited by 137
A new type of p16INK4/MTS1 gene transcript expressed in B-cell malignancies.
Duro, D., Bernard, O., Della-Valle, V., Berger, R., & Larsen, C. (1995) · PubMed · Cited by 130
Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases
Kraehn, G., Utikal, J. S., Udart, M., Greulich, K. M., Bezold, G., Kaskel, P., Leiter, U., & Peter, R. U. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1535 · Cited by 128
Met–HGF/SF: Tumorigenesis, Invasion and Metastasis
Woude, G. F. V., Jeffers, M., Cortner, J., Alvord, G., Tsarfaty, I., & Resau, J. H. (2007) · Novartis Foundation symposium · doi:10.1002/9780470515457.ch8 · Cited by 124
Straume, O., Smeds, J., Kumar, R., Hemminki, K., & Akslen, L. A. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64174-0 · Cited by 124
Fountain, J. W., Bale, S. J., Housman, D. E., & Dracopoli, N. C. (1990) · PubMed · Cited by 124
Components of the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model
Kannan, K., Sharpless, N. E., Xu, J., O’Hagan, R. C., Bosenberg, M., & Chin, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0336397100 · Cited by 120
Self-citationBasic fibroblast growth factor induces a transformed phenotype in normal human melanocytes
Nesbit, M., Nesbit, H. K., Bennett, J., Andl, T., Hsu, M., Dejesus, E., McBrian, M., Gupta, A. R., Eck, S. L., & Herlyn, M. (1999) · Oncogene · doi:10.1038/sj.onc.1203066 · Cited by 117
Noonan, F. P., Otsuka, T., Bang, S., Anver, M. R., & Merlino, G. T. (2000) · PubMed · Cited by 113
Donawho, C. K., & Kripke, M. L. (1991) · PubMed · Cited by 102
Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo
Sharpless, N. E., Kannan, K., Xu, J., Bosenberg, M., & Chin, L. (2003) · Oncogene · doi:10.1038/sj.onc.1206809 · Cited by 101
Self-citationIn vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma
Robertson, G. P., Furnari, F. B., Miele, M. E., Glendening, M. J., Welch, D. R., Fountain, J. W., LUGO, T. G., Huang, H., & Cavenee, W. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9418 · Cited by 97
Genetics, Development, and Malignancy of Melanocytes
Bennett, D. C. (1993) · International review of cytology · doi:10.1016/s0074-7696(08)60383-6 · Cited by 96
UV-induction of keratinocyte endothelin-1 downregulates E-cadherin in melanocytes and melanoma cells
Jamal, S., & Schneider, R. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13729 · Cited by 96
Kumar, R., Smeds, J., Berggren, P., Straume, O., Rozell, B. L., Akslen, L. A., & Hemminki, K. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20011120)95:6<388::aid-ijc1069>3.0.co;2-6 · Cited by 96
Jafari, M., Papp, T., Kirchner, S., Kiener, U., Henschler, D., Burg, G., & Schiffmann, D. (1995) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01202725 · Cited by 94
Ink4a/arf deficiency promotes ultraviolet radiation-induced melanomagenesis.
Recio, J. A., Noonan, F. P., Takayama, H., Anver, M. R., Duray, P. H., Rush, W. L., Lindner, G., Fabo, E. C. D., DePinho, R. A., & Merlino, G. T. (2002) · PubMed · Cited by 93
UV-induction of keratinocyte endothelin-1 downregulates E-cadherin in melanocytes and melanoma cells
Jamal, S., & Schneider, R. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213729 · Cited by 92
UVB induces atypical melanocytic lesions and melanoma in human skin.
Atillasoy, E. S., Seykora, J. T., Soballe, P. W., Elenitsas, R., Nesbit, M., Elder, D. E., Montone, K. T., Sauter, E. R., & Herlyn, M. (1998) · Europe PMC (PubMed Central) · Cited by 90
Low Prevalence of Germline CDKN2A and CDK4 Mutations in Patients With Early-Onset Melanoma
Tsao, H., Zhang, X., Kwitkiwski, K., Finkelstein, D. M., Sober, A. J., & Haluska, F. G. (2000) · Archives of Dermatology · doi:10.1001/archderm.136.9.1118 · Cited by 87
p16/CDKN2 andCDK4 gene mutations in sporadic melanoma development and progression
Piccinin, S., Doglioni, C., Maestro, R., Vukosavijevic, T., Gasparotto, D., D'Orazi, C., & Boiocchi, M. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970220)74:1<26::aid-ijc5>3.0.co;2-2 · Cited by 85
Powell, M. B., Hyman, P., Bell, O. D., Balmain, A., Brown, K., Alberts, D., & Bowden, G. T. (1995) · Molecular Carcinogenesis · doi:10.1002/mc.2940120205 · Cited by 84
Novel mutations in the p16/CDKN2A binding region of the cyclin-dependent kinase-4 gene.
Tsao, H., Benoit, E., Sober, A. J., Thiele, C. J., & Haluska, F. G. (1998) · PubMed · Cited by 81
YANASE, H., Ando, H., Horikawa, M., Watanabe, M., Mori, T., & Matsuda, N. (2001) · Pigment Cell Research · doi:10.1034/j.1600-0749.2001.140205.x · Cited by 79
Gisselsson, D., Höglund, M., Mertens, F., Mitelman, F., & Mandahl, N. (1998) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199811)23:3<273::aid-gcc11>3.0.co;2-n · Cited by 78
The cancer-chromatin connection
DePinho, R. A. (1998) · Nature · doi:10.1038/35257 · Cited by 76
Photocarcinogenesis in human adult skin grafts
Berking, C. (2002) · Carcinogenesis · doi:10.1093/carcin/23.1.181 · Cited by 75
Glendening, J. M., Flores, J. F., Walker, G. J., Stone, S., Albino, A. P., & Fountain, J. W. (1995) · PubMed · Cited by 69
p16INK4a inactivation is not frequent in uncultured sporadic primary cutaneous melanoma
Fujimoto, A., Morita, R., Hatta, N., Takehara, K., & Takata, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202803 · Cited by 67
p16(INK4a) and p53 deficiency cooperate in tumorigenesis.
Sharpless, N. E., Alson, S., Chan, S., Silver, D. P., Castrillón, D. H., & DePinho, R. A. (2002) · PubMed · Cited by 63
Mutagenicity of melanin from human red hair
Harsanyl, Z. P., Post, P. W., Brinkmann, J. P., Chedekel, M. R., & Deibel, R. M. (1980) · Cellular and Molecular Life Sciences · doi:10.1007/bf01952282 · Cited by 60
Mutations of the p16 gene in gliomas.
Kyritsis, A. P., Zhang, B., Zhang, W., Xiao, M., Takeshima, H., Bondy, M. L., Cunningham, J. E., Levin, V. A., & Bruner, J. (1996) · PubMed · Cited by 47
Papp, T. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.2.e14 · Cited by 32
Genetic dissection of melanoma pathways in the mouse
Yang, F. C., Merlino, G. T., & Chin, L. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0376 · Cited by 28
Self-citationUV Fingerprint CDKN2a but No p14ARF Mutations in Sporadic Melanomas
Peris, K., Chimenti, S., Fargnoli, M. C., et al. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00575.x · Cited by 27
Cloning and Characterization of the CDKN2A and p19ARF Genes from Monodelphis domestica
SHERBURN, T. E., Gale, J. M., & Ley, R. D. (1998) · DNA and Cell Biology · doi:10.1089/dna.1998.17.975 · Cited by 13
Cited by
G-protein-coupled receptors and cancer
Dorsam, R. T., & Gutkind, J. S. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2069 · Cited by 1,388
The metastatic niche: adapting the foreign soil
Psaila, B., & Lyden, D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2621 · Cited by 1,300
BrafV600E cooperates with Pten loss to induce metastatic melanoma
Dankort, D., Curley, D. P., Cartlidge, R. A., Nelson, B., Karnezis, A. N., Damsky Jr, W. E., You, M. J., DePinho, R. A., McMahon, M., & Bosenberg, M. (2009) · Nature Genetics · doi:10.1038/ng.356 · Cited by 1,189
Melanoma genome sequencing reveals frequent PREX2 mutations
Berger, M. F., Hodis, E., Heffernan, T. P., Deribe, Y. L., Lawrence, M. S., Protopopov, A., Ivanova, E., Watson, I. R., Nickerson, E., Ghosh, P., et al. (2012) · Nature · doi:10.1038/nature11071 · Cited by 756
Self-citationPatton, E. E., Widlund, H. R., Kutok, J. L., Kopani, K. R., Amatruda, J. F., Murphey, R. D., Berghmans, S., Mayhall, E. A., Traver, D., Fletcher, C. D. M., et al. (2005) · Current Biology · doi:10.1016/j.cub.2005.01.031 · Cited by 664
Metadata
- Authors
- Chin, L.
- Venue
- Nature Reviews Cancer
- Published
- 2003-08-01
- Volume
- 3
- Issue
- 8
- Pages
- 559-570
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2076506898
- Cited by
- 302
- References
- 159
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.